Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy.

Zhou Z, Tang K, Zhang G, Wadonda-Kabondo N, Moyo K, Rowe LA, DeVos JR, Wagar N, Zheng DP, Guo H, Nkengasong J, Frace M, Sammons S, Yang C.

Afr J Lab Med. 2018 May 30;7(1):708. doi: 10.4102/ajlm.v7i1.708. eCollection 2018.

2.

Effective interactions and dynamics of small passive particles in an active bacterial medium.

Semeraro EF, Devos JM, Narayanan T.

J Chem Phys. 2018 May 28;148(20):204905. doi: 10.1063/1.5026778.

PMID:
29865804
3.

Dynamic self-assembly of DNA minor groove-binding ligand DB921 into nanotubes triggered by an alkali halide.

Mizuta R, Devos JM, Webster J, Ling WL, Narayanan T, Round A, Munnur D, Mossou E, Farahat AA, Boykin DW, Wilson WD, Neidle S, Schweins R, Rannou P, Haertlein M, Forsyth VT, Mitchell EP.

Nanoscale. 2018 Mar 28;10(12):5550-5558. doi: 10.1039/c7nr03875e. Epub 2018 Mar 8.

4.

Solution structure of the cytochrome P450 reductase-cytochrome c complex determined by neutron scattering.

Freeman SL, Martel A, Devos JM, Basran J, Raven EL, Roberts GCK.

J Biol Chem. 2018 Apr 6;293(14):5210-5219. doi: 10.1074/jbc.RA118.001941. Epub 2018 Feb 23.

5.

Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function.

Rengachari S, Groiss S, Devos JM, Caron E, Grandvaux N, Panne D.

Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E601-E609. doi: 10.1073/pnas.1718426115. Epub 2018 Jan 9.

6.

In vivo analysis of the Escherichia coli ultrastructure by small-angle scattering.

Semeraro EF, Devos JM, Porcar L, Forsyth VT, Narayanan T.

IUCrJ. 2017 Sep 26;4(Pt 6):751-757. doi: 10.1107/S2052252517013008. eCollection 2017 Nov 1.

7.

Inactivation of Escherichia coli O157:H7 in Minute Steaks Cooked under Selected Conditions.

Yang X, Devos J, Klassen MD.

J Food Prot. 2017 Oct;80(10):1641-1647. doi: 10.4315/0362-028X.JFP-17-081.

PMID:
28853628
8.

Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation.

Islam AK, Sinha N, DeVos JM, Kaleekal TS, Jyothula SS, Teeter LD, Nguyen DTM, Eagar TN, Moore LW, Puppala M, Wong STC, Knight RJ, Frost AE, Graviss EA, Osama Gaber A.

Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13028. Epub 2017 Jul 7.

PMID:
28658512
9.

High Prevalence of Abacavir-associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy.

Dziuban EJ, DeVos J, Ngeno B, Ngugi E, Zhang G, Sabatier J, Wagar N, Diallo K, Nganga L, Katana A, Yang C, Rivadeneira ED, Mukui I, Odhiambo F, Redfield R, Raizes E.

Pediatr Infect Dis J. 2017 Aug;36(8):758-760. doi: 10.1097/INF.0000000000001597.

PMID:
28383390
10.

A multi-country study to assess the effect of a treatment with moxidectin pour-on during the dry period on milk production in dairy cows.

Geurden T, Bartram DJ, Vanimisetti HB, Fanke J, Camuset P, Devos J, Sawyer A, von Samson-Himmelstjerna G, Demeler J, Charlier J.

Vet Parasitol. 2017 Apr 15;237:104-109. doi: 10.1016/j.vetpar.2017.02.010. Epub 2017 Feb 20.

PMID:
28259556
11.

SEC-SANS: size exclusion chromatography combined in situ with small-angle neutron scattering.

Jordan A, Jacques M, Merrick C, Devos J, Forsyth VT, Porcar L, Martel A.

J Appl Crystallogr. 2016 Nov 2;49(Pt 6):2015-2020. eCollection 2016 Dec 1.

12.

Direct visualization of a Fe(IV)-OH intermediate in a heme enzyme.

Kwon H, Basran J, Casadei CM, Fielding AJ, Schrader TE, Ostermann A, Devos JM, Aller P, Blakeley MP, Moody PC, Raven EL.

Nat Commun. 2016 Nov 29;7:13445. doi: 10.1038/ncomms13445.

13.

Spatial and Temporal Distribution of Escherichia coli on Beef Trimmings Obtained from a Beef Packing Plant.

Visvalingam J, Wang H, Youssef MK, Devos J, Gill CO, Yang X.

J Food Prot. 2016 Aug;79(8):1325-31. doi: 10.4315/0362-028X.JFP-15-598.

PMID:
27497119
14.

Temporal patterns of damage and decay kinetics of DNA retrieved from plant herbarium specimens.

Weiß CL, Schuenemann VJ, Devos J, Shirsekar G, Reiter E, Gould BA, Stinchcombe JR, Krause J, Burbano HA.

R Soc Open Sci. 2016 Jun 22;3(6):160239. doi: 10.1098/rsos.160239. eCollection 2016 Jun.

15.

Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008-2010.

Mungati M, Mhangara M, Gonese E, Mugurungi O, Dzangare J, Ngwende S, Musasa P, Wellington M, Shambira G, Apollo T, Yang C, DeVos J, Sabatier J, Kilmarx P, Chakanyuka-Musanhu C, Tshimanga M.

BMC Res Notes. 2016 Jun 10;9:302. doi: 10.1186/s13104-016-2101-8.

16.

Epigenome confrontation triggers immediate reprogramming of DNA methylation and transposon silencing in Arabidopsis thaliana F1 epihybrids.

Rigal M, Becker C, Pélissier T, Pogorelcnik R, Devos J, Ikeda Y, Weigel D, Mathieu O.

Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2083-92. doi: 10.1073/pnas.1600672113. Epub 2016 Mar 21.

17.

Inactivation of Escherichia coli O157:H7 in Beef Roasts Cooked in Conventional or Convection Ovens or in a Slow Cooker under Selected Conditions.

Gill CO, Devos J, Badoni M, Yang X.

J Food Prot. 2016 Feb;79(2):205-12. doi: 10.4315/0362-028X.JFP-15-116.

PMID:
26818980
18.

Biomolecular Deuteration for Neutron Structural Biology and Dynamics.

Haertlein M, Moulin M, Devos JM, Laux V, Dunne O, Forsyth VT.

Methods Enzymol. 2016;566:113-57. doi: 10.1016/bs.mie.2015.11.001. Epub 2015 Dec 22.

PMID:
26791978
19.

Prevalence of transmitted HIV-1 drug resistance among young adults attending HIV counselling and testing clinics in Kigali, Rwanda.

Mutagoma M, Ndahimana Jd, Kayirangwa E, Dahourou AG, Balisanga H, DeVos JR, McAlister D, Yang C, Bertagnolio S, Riedel DJ, Nsanzimana S.

Antivir Ther. 2016;21(3):247-51. doi: 10.3851/IMP2999. Epub 2015 Oct 12.

PMID:
26458150
20.

Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire.

Devos J, Van Praet C, Decaestecker K, Claeys T, Fonteyne V, Decalf V, De Meerleer G, Ost P, Lumen N.

Acta Clin Belg. 2015 Aug;70(4):272-9. doi: 10.1179/2295333715Y.0000000015. Epub 2015 Mar 27.

PMID:
25816107
21.

Kinetics and anthelmintic efficacy of topical eprinomectin when given orally to goats.

Badie C, Lespine A, Devos J, Sutra JF, Chartier C.

Vet Parasitol. 2015 Apr 15;209(1-2):56-61. doi: 10.1016/j.vetpar.2015.02.013. Epub 2015 Feb 20.

PMID:
25744609
22.

Observations on the use of cidofovir for BK virus infection in renal transplantation.

Kuten SA, Patel SJ, Knight RJ, Gaber LW, DeVos JM, Gaber AO.

Transpl Infect Dis. 2014 Dec;16(6):975-83. doi: 10.1111/tid.12313. Epub 2014 Nov 21.

PMID:
25412701
23.

Barriers to preemptive renal transplantation: a single center questionnaire study.

Knight RJ, Teeter LD, Graviss EA, Patel SJ, DeVos JM, Moore LW, Gaber AO.

Transplantation. 2015 Mar;99(3):576-9. doi: 10.1097/TP.0000000000000357.

PMID:
25083616
24.

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping.

Parry CM, Parkin N, Diallo K, Mwebaza S, Batamwita R, DeVos J, Bbosa N, Lyagoba F, Magambo B, Jordan MR, Downing R, Zhang G, Kaleebu P, Yang C, Bertagnolio S.

J Clin Microbiol. 2014 Aug;52(8):2868-75. doi: 10.1128/JCM.00544-14. Epub 2014 May 28.

25.

Effects of selected cooking procedures on the survival of Escherichia coli O157:H7 in inoculated steaks cooked on a hot plate or gas barbecue grill.

Gill CO, Devos J, Youssef MK, Yang X.

J Food Prot. 2014 Jun;77(6):919-26. doi: 10.4315/0362-028X.JFP-13-526.

PMID:
24853513
26.

Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection.

Devos JM, Gaber AO, Teeter LD, Graviss EA, Patel SJ, Land GA, Moore LW, Knight RJ.

Transplantation. 2014 Mar 15;97(5):534-40. doi: 10.1097/01.TP.0000438196.30790.66.

PMID:
24595116
27.

Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance.

Zheng DP, Rodrigues M, Bile E, Nguyen DB, Diallo K, DeVos JR, Nkengasong JN, Yang C.

PLoS One. 2013 Oct 17;8(10):e77649. doi: 10.1371/journal.pone.0077649. eCollection 2013.

28.

Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy.

Knight RJ, Gaber LW, Patel SJ, DeVos JM, Moore LW, Gaber AO.

Transplantation. 2013 Oct 15;96(7):e51. doi: 10.1097/TP.0b013e3182a68935. No abstract available.

PMID:
24100844
29.

Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay.

Zhang G, Cai F, Zhou Z, DeVos J, Wagar N, Diallo K, Zulu I, Wadonda-Kabondo N, Stringer JS, Weidle PJ, Ndongmo CB, Sikazwe I, Sarr A, Kagoli M, Nkengasong J, Gao F, Yang C.

J Clin Microbiol. 2013 Nov;51(11):3666-74. doi: 10.1128/JCM.01669-13. Epub 2013 Aug 28.

30.

Outcomes of living donor renal transplants with a negative cross-match and pretransplant donor-specific antibody.

Knight RJ, Devos JM, Patel SJ, Land G, Moore LW, Gaber L, Gaber AO.

Transplant Proc. 2013 May;45(4):1399-401. doi: 10.1016/j.transproceed.2013.01.027.

PMID:
23726582
31.

A single early introduction of HIV-1 subtype B into Central America accounts for most current cases.

Murillo W, Veras N, Prosperi M, de Rivera IL, Paz-Bailey G, Morales-Miranda S, Juarez SI, Yang C, DeVos J, Marín JP, Mild M, Albert J, Salemi M.

J Virol. 2013 Jul;87(13):7463-70. doi: 10.1128/JVI.01602-12. Epub 2013 Apr 24.

32.

Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.

Knight RJ, Gaber LW, Patel SJ, DeVos JM, Moore LW, Gaber AO.

Transplantation. 2013 Apr 15;95(7):949-54. doi: 10.1097/TP.0b013e31828423cd.

PMID:
23545506
33.

Crystal structure and mechanism of activation of TANK-binding kinase 1.

Larabi A, Devos JM, Ng SL, Nanao MH, Round A, Maniatis T, Panne D.

Cell Rep. 2013 Mar 28;3(3):734-46. doi: 10.1016/j.celrep.2013.01.034. Epub 2013 Feb 28.

34.

High-dose insulin therapy for neurogenic-stunned myocardium after stroke.

Devos J, Peeters A, Wittebole X, Hantson P.

BMJ Case Rep. 2012 Nov 21;2012. pii: bcr2012006620. doi: 10.1136/bcr-2012-006620.

35.

Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.

DeVos JM, Gaber AO, Knight RJ, Land GA, Suki WN, Gaber LW, Patel SJ.

Kidney Int. 2012 Sep;82(5):598-604. doi: 10.1038/ki.2012.190. Epub 2012 May 23.

36.

Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.

Wadonda-Kabondo N, Bennett D, van Oosterhout JJ, Moyo K, Hosseinipour M, Devos J, Zhou Z, Aberle-Grasse J, Warne TR, Mtika C, Chilima B, Banda R, Pasulani O, Porter C, Phiri S, Jahn A, Kamwendo D, Jordan MR, Kabuluzi S, Chimbwandira F, Kagoli M, Matatiyo B, Demby A, Yang C.

Clin Infect Dis. 2012 May;54 Suppl 4:S362-8. doi: 10.1093/cid/cir987.

37.

Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy.

Rottinghaus EK, Ugbena R, Diallo K, Bassey O, Azeez A, Devos J, Zhang G, Aberle-Grasse J, Nkengasong J, Yang C.

Clin Infect Dis. 2012 Apr;54(8):1187-95. doi: 10.1093/cid/cis015. Epub 2012 Mar 12.

PMID:
22412066
38.

Magel2, a Prader-Willi syndrome candidate gene, modulates the activities of circadian rhythm proteins in cultured cells.

Devos J, Weselake SV, Wevrick R.

J Circadian Rhythms. 2011 Dec 30;9(1):12. doi: 10.1186/1740-3391-9-12.

39.

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.

Zhou Z, Wagar N, DeVos JR, Rottinghaus E, Diallo K, Nguyen DB, Bassey O, Ugbena R, Wadonda-Kabondo N, McConnell MS, Zulu I, Chilima B, Nkengasong J, Yang C.

PLoS One. 2011;6(11):e28184. doi: 10.1371/journal.pone.0028184. Epub 2011 Nov 23.

40.

Making a difference: an interview with Sister Jeanne Devos promoting social justice for the underserved. [Interviewed by Michael Glasser].

Devos J.

Educ Health (Abingdon). 2011 Apr;24(1):660. Epub 2011 Apr 28. No abstract available.

PMID:
21710429
41.

De novo donor specific antibodies and patient outcomes in renal transplantation.

DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.

Clin Transpl. 2011:351-8.

PMID:
22755430
42.

Structural analysis of bacteriophage T4 DNA replication: a review in the Virology Journal series on bacteriophage T4 and its relatives.

Mueser TC, Hinerman JM, Devos JM, Boyer RA, Williams KJ.

Virol J. 2010 Dec 3;7:359. doi: 10.1186/1743-422X-7-359. Review.

43.

A synthetic adjuvant to enhance and expand immune responses to influenza vaccines.

Coler RN, Baldwin SL, Shaverdian N, Bertholet S, Reed SJ, Raman VS, Lu X, DeVos J, Hancock K, Katz JM, Vedvick TS, Duthie MS, Clegg CH, Van Hoeven N, Reed SG.

PLoS One. 2010 Oct 27;5(10):e13677. doi: 10.1371/journal.pone.0013677.

44.

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM.

N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10.

45.

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.

Galli G, Hancock K, Hoschler K, DeVos J, Praus M, Bardelli M, Malzone C, Castellino F, Gentile C, McNally T, Del Giudice G, Banzhoff A, Brauer V, Montomoli E, Zambon M, Katz J, Nicholson K, Stephenson I.

Proc Natl Acad Sci U S A. 2009 May 12;106(19):7962-7. doi: 10.1073/pnas.0903181106. Epub 2009 Apr 27.

46.

Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase.

Maby-El Hajjami H, Amé-Thomas P, Pangault C, Tribut O, DeVos J, Jean R, Bescher N, Monvoisin C, Dulong J, Lamy T, Fest T, Tarte K.

Cancer Res. 2009 Apr 1;69(7):3228-37. doi: 10.1158/0008-5472.CAN-08-3000. Epub 2009 Mar 10.

47.

A finite element analysis of the vibrational behaviour of the intra-operatively manufactured prosthesis-femur system.

Pastrav LC, Devos J, Van der Perre G, Jaecques SV.

Med Eng Phys. 2009 May;31(4):489-94. doi: 10.1016/j.medengphy.2008.11.017. Epub 2009 Jan 10.

PMID:
19136292
48.

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

Stephenson I, Nicholson KG, Hoschler K, Zambon MC, Hancock K, DeVos J, Katz JM, Praus M, Banzhoff A.

N Engl J Med. 2008 Oct 9;359(15):1631-3. doi: 10.1056/NEJMc0805274. No abstract available.

49.

Crystal structure of bacteriophage T4 5' nuclease in complex with a branched DNA reveals how flap endonuclease-1 family nucleases bind their substrates.

Devos JM, Tomanicek SJ, Jones CE, Nossal NG, Mueser TC.

J Biol Chem. 2007 Oct 26;282(43):31713-24. Epub 2007 Aug 9.

50.

Serologic survey for pathogens potentially affecting pronghorn (Antilocapra americana) fawn recruitment in Arizona, USA.

Dubay SA, Noon TH, deVos JC Jr, Ockenfels RA.

J Wildl Dis. 2006 Oct;42(4):844-8.

PMID:
17255453

Supplemental Content

Support Center